Repaglinide .5 mg/1
Repaglinide · TABLET · NorthStar RxLLC
No Recall History
Plain English
Repaglinide is a tablet containing repaglinide at .5 mg/1, taken oral. Manufactured by NorthStar RxLLC.
Key Facts
- Brand Name
- Repaglinide
- Generic Name
- Repaglinide
- NDC Code (Product)
72603-810- Manufacturer
- NorthStar RxLLC
- Strength
- .5 mg/1
- Dosage Form
- TABLET
- Route
- ORAL
- Marketing Status
- Application #
- ANDA207209
- Drug Class
- Glinide [EPC]
- Marketing Start
- 04/08/2025
Recall History
No Recall HistoryFrequently Asked Questions
What is Repaglinide used for?
Repaglinide contains Repaglinide. It is a tablet taken oral. Consult your doctor for specific uses.
Is Repaglinide a controlled substance?
Repaglinide is not classified as a controlled substance by the DEA.
What is the generic name for Repaglinide?
The generic name for Repaglinide is Repaglinide. There are no other listed brand versions of Repaglinide.
What is the NDC code for Repaglinide .5 mg/1?
The NDC (National Drug Code) for Repaglinide .5 mg/1 is 72603-810, listed by NorthStar RxLLC.
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)